Core Laboratories (CLB) Stock Price

Core Laboratories Price

Euronext·CLOSED
11.41USD+0.22 (+1.95 %)
Market closed

Revenue at Core Laboratories has contracted by 0.5% per year over the past 19 years to 526.52 M USD. Earnings per share have declined at 4.2% per year over the last 19 years. Core Laboratories's net margin stands at 6.0%, up from 4.2% several years earlier. Core Laboratories currently offers a dividend yield of about 0.35%. The payout ratio is around 6% of earnings. Analysts set a median price target of 14.28 USD, implying 25.2% above the current price. Of 10 analysts, 1 rate the stock a buy — an overall Sell consensus. Over the past year Core Laboratories shares have lost 9.6%. The stock trades about 17% above its 52-week low.

Core Laboratories stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Core Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Core Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Core Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Core Laboratories Stock Price History
DateCore Laboratories Price
7/21/202611.41 USD
7/20/202611.19 USD
7/17/202611.34 USD
7/16/202611.49 USD
7/15/202611.36 USD
7/14/202611.55 USD
7/13/202611.59 USD
7/10/202611.10 USD
7/9/202610.99 USD
7/8/202610.98 USD
7/7/202610.89 USD
7/6/202611.40 USD
7/2/202611.46 USD
7/1/202611.57 USD
6/30/202611.65 USD
6/29/202610.78 USD
6/26/202611.02 USD
6/25/202610.92 USD
6/24/202610.72 USD
6/23/202611.64 USD
6/22/202611.77 USD
6/18/202611.69 USD
6/17/202611.43 USD
6/16/202612.19 USD
6/15/202612.72 USD
6/12/202613.34 USD
6/11/202613.32 USD
6/10/202613.42 USD
6/5/202612.93 USD
6/4/202613.66 USD
6/3/202613.36 USD
6/2/202613.60 USD
6/1/202613.87 USD
5/29/202613.67 USD
5/28/202613.94 USD
5/27/202614.02 USD
5/26/202614.54 USD
5/22/202614.22 USD
5/21/202614.50 USD
5/20/202613.75 USD
5/19/202613.72 USD
5/14/202613.49 USD
4/29/202617.30 USD
4/28/202616.77 USD
4/27/202617.29 USD
4/24/202617.45 USD
4/22/202617.06 USD
4/21/202616.64 USD
4/20/202616.33 USD
4/16/202616.92 USD
4/15/202616.46 USD
4/14/202616.27 USD
4/13/202617.07 USD
4/9/202616.61 USD
4/8/202616.76 USD
4/7/202617.26 USD
4/6/202616.61 USD
4/2/202616.33 USD
4/1/202616.11 USD
3/31/202616.79 USD
3/30/202616.76 USD
3/27/202617.61 USD
3/26/202616.42 USD
3/25/202615.85 USD
3/24/202615.71 USD
3/23/202616.87 USD
3/20/202616.21 USD
3/19/202615.97 USD
3/18/202616.06 USD
3/17/202616.29 USD
3/16/202615.77 USD
3/13/202615.77 USD
3/12/202615.90 USD
3/11/202616.42 USD
3/10/202616.33 USD
3/9/202616.32 USD
3/6/202615.91 USD
3/5/202616.11 USD
3/4/202616.54 USD
3/3/202616.88 USD
3/2/202617.28 USD
2/27/202617.59 USD
2/26/202617.40 USD
2/25/202617.52 USD
2/24/202617.57 USD
2/23/202618.33 USD
2/20/202618.42 USD
2/19/202618.63 USD
2/18/202618.47 USD
2/17/202618.75 USD
2/13/202618.56 USD
2/12/202618.15 USD
2/11/202618.94 USD
2/10/202618.64 USD
2/9/202618.98 USD
2/6/202618.56 USD
2/5/202618.78 USD
2/4/202619.61 USD
2/3/202619.64 USD
2/2/202619.59 USD
1/30/202619.54 USD
1/29/202619.64 USD
1/28/202618.82 USD
1/27/202619.67 USD
1/26/202619.32 USD
1/23/202619.46 USD
1/22/202619.63 USD
1/21/202619.53 USD
1/20/202618.51 USD
1/16/202619.43 USD
1/15/202619.62 USD
1/14/202619.43 USD
1/13/202619.00 USD
1/12/202618.78 USD
1/9/202618.97 USD
1/8/202618.88 USD
1/7/202618.03 USD
1/6/202618.16 USD
1/5/202618.13 USD
1/2/202616.95 USD
12/31/202516.03 USD
12/30/202516.12 USD
12/29/202516.30 USD
12/26/202516.36 USD
12/24/202516.53 USD
12/23/202516.61 USD
12/22/202516.59 USD
12/19/202516.24 USD
12/18/202516.06 USD
12/17/202516.21 USD
12/16/202516.08 USD
12/15/202516.55 USD
12/12/202516.48 USD
12/11/202517.01 USD
12/10/202517.02 USD
12/9/202516.80 USD
12/8/202516.43 USD
12/5/202516.83 USD
12/4/202516.49 USD
12/3/202516.42 USD
12/2/202515.73 USD
12/1/202515.39 USD
11/28/202515.10 USD
11/26/202514.95 USD
11/25/202515.04 USD
11/24/202514.74 USD
11/21/202514.72 USD
11/20/202513.89 USD
11/19/202514.92 USD
11/18/202515.32 USD
11/17/202515.14 USD
11/14/202515.39 USD
11/13/202515.06 USD
11/12/202515.44 USD
11/11/202516.15 USD
11/10/202515.46 USD
11/7/202515.35 USD
11/6/202515.29 USD
11/5/202515.70 USD
11/4/202515.83 USD
11/3/202516.15 USD
10/31/202515.94 USD
10/30/202515.96 USD
10/29/202516.11 USD
10/28/202516.47 USD
10/27/202516.86 USD
10/23/202516.45 USD
10/22/202512.77 USD
10/21/202512.04 USD
10/20/202511.85 USD
10/16/202511.41 USD
10/15/202511.86 USD
10/14/202511.43 USD
10/13/202510.95 USD
10/9/202510.98 USD
10/8/202512.08 USD
10/7/202511.92 USD
10/6/202512.38 USD
10/2/202511.98 USD
10/1/202512.58 USD
9/30/202512.36 USD
9/29/202512.56 USD
9/25/202512.40 USD
9/24/202512.49 USD
9/23/202512.29 USD
9/22/202512.13 USD
9/18/202512.68 USD
9/17/202512.48 USD
9/16/202512.85 USD
9/15/202512.44 USD
9/11/202512.67 USD
9/10/202512.30 USD
9/9/202512.81 USD
9/8/202512.41 USD
9/4/202512.48 USD
9/3/202511.79 USD
9/2/202511.74 USD
8/28/202511.32 USD
8/27/202511.14 USD
8/26/202511.12 USD
8/25/202511.09 USD
8/21/202510.46 USD
8/20/202510.34 USD
8/19/202510.43 USD
8/18/202510.50 USD
8/14/202510.60 USD
8/13/202510.74 USD
8/12/202510.43 USD
8/11/20259.74 USD
8/7/202510.27 USD
8/6/202510.29 USD
8/5/202510.74 USD
8/4/202510.56 USD
7/31/202510.94 USD
7/30/202511.14 USD
7/29/202511.58 USD
7/28/202511.95 USD
7/24/202513.36 USD
7/23/202512.62 USD
Access this data via the Eulerpool API
Get Free API Key

Core Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
509.79 M USD
57.36 M USD
36.68 M USD
Jan 1, 2024
523.85 M USD
60.77 M USD
31.40 M USD
Jan 1, 2025
526.52 M USD
56.47 M USD
31.80 M USD
Jan 1, 2026 (e)
545.70 M USD
58.88 M USD
38.58 M USD
Jan 1, 2027 (e)
516.86 M USD
66.67 M USD
37.57 M USD
Jan 1, 2028 (e)
614.08 M USD
97.97 M USD
64.12 M USD
Jan 1, 2029 (e)
632.26 M USD
112.11 M USD
75.52 M USD
Jan 1, 2030 (e)
650.44 M USD
0.00 USD
90.72 M USD

Core Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 23, 2026, 8:45 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.800.590.650.700.670.490.470.490.510.520.530.550.520.610.630.65
-26.54-25.979.668.19-4.57-27.10-3.494.044.092.750.573.61-5.3218.992.932.85
33.1225.7628.1329.0025.7523.0021.7019.6321.4119.6920.5320.5320.5320.5320.5320.53
264.00152.00182.00203.00172.00112.00102.0096.00109.00103.00108.00111.90105.95126.07129.76133.46
188.0088.00111.00120.0096.0059.0043.0044.0057.0060.0056.0058.0066.0097.00112.00–
23.5914.9217.1617.1414.3712.119.159.0011.2011.4710.6510.6412.7915.8017.72–
114.0063.0083.0079.00102.00-97.0019.0019.0036.0031.0031.0038.0037.0064.0075.0090.00
-55.64-44.7431.75-4.8229.11-195.10-119.59–89.47-13.89–22.58-2.6372.9717.1920.00
2.202.202.202.202.200.280.040.040.040.040.040.040.040.04––
10.00––––-87.27-85.71–––––––––
42.9043.7044.3044.5044.6044.5046.7046.8047.5247.6947.0347.0347.0347.0347.0347.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Core Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Core Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Core Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Core Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Core Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Core Laboratories stock margins

The Core Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Core Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Core Laboratories.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
21.77 %
9.29 %
4.19 %
Jan 1, 2022
19.62 %
8.99 %
3.98 %
Jan 1, 2023
21.54 %
11.25 %
7.19 %
Jan 1, 2024
19.72 %
11.60 %
5.99 %
Jan 1, 2025
20.69 %
10.72 %
6.04 %
Jan 1, 2026 (e)
20.69 %
10.79 %
7.07 %
Jan 1, 2027 (e)
20.69 %
12.90 %
7.27 %
Jan 1, 2028 (e)
20.69 %
15.95 %
10.44 %

Core Laboratories Stock Revenue, EBIT, Earnings per Share

The Core Laboratories earnings per share therefore indicates how much revenue Core Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
10.07 USD
0.94 USD
0.42 USD
Jan 1, 2022
10.46 USD
0.94 USD
0.42 USD
Jan 1, 2023
10.73 USD
1.21 USD
0.77 USD
Jan 1, 2024
10.99 USD
1.27 USD
0.66 USD
Jan 1, 2025
11.20 USD
1.20 USD
0.68 USD
Jan 1, 2026 (e)
11.60 USD
1.25 USD
0.82 USD
Jan 1, 2027 (e)
10.99 USD
1.42 USD
0.80 USD
Jan 1, 2028 (e)
13.06 USD
2.08 USD
1.36 USD

Core Laboratories business model & stock analysis

Core Laboratories Segments

Core Laboratories Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • Max

Service
Product
Details
Date
Service
Product
Jan 1, 2014
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
Jan 1, 2018
387.10 M USD
25.98 M USD

Core Laboratories Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Operating Segment Production Enhancement
Operating Segment Reservoir Description
Operating Segment Reservoir Management
Corporate and Other
Operating Segment Corporate And Other
Details
Date
Operating Segment Production Enhancement
Operating Segment Reservoir Description
Operating Segment Reservoir Management
Corporate and Other
Operating Segment Corporate And Other
Jan 1, 2014
2.46 M USD
10.39 M USD
366,000.00 USD
0.00 USD
-13.21 M USD
Jan 1, 2015
1.84 M USD
8.67 M USD
248,000.00 USD
0.00 USD
-10.76 M USD
Jan 1, 2016
877,000.00 USD
3.94 M USD
121,000.00 USD
0.00 USD
-4.94 M USD
Jan 1, 2017
1.19 M USD
294,000.00 USD
0.00 USD
0.00 USD
-1.48 M USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Core Laboratories Revenue by Region

  • 3 Years

  • 5 Years

  • Max

Other Countries Member
Other Countries
United States
Canada
Details
Date
Other Countries Member
Other Countries
United States
Canada
Jan 1, 2018
0.00 USD
342.14 M USD
324.07 M USD
34.63 M USD
Jan 1, 2019
353.80 M USD
0.00 USD
289.17 M USD
25.24 M USD
Jan 1, 2020
328.33 M USD
0.00 USD
158.94 M USD
0.00 USD
Jan 1, 2021
0.00 USD
322.07 M USD
148.18 M USD
0.00 USD
Jan 1, 2022
323.03 M USD
0.00 USD
166.70 M USD
0.00 USD

Core Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Core Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

Core Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Core Laboratories shares outstanding

The number of shares of Core Laboratories was 47.03 M in 2025. This indicates how many shares Core Laboratories is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
46.70 M Stocks
Jan 1, 2022
46.80 M Stocks
Jan 1, 2023
47.52 M Stocks
Jan 1, 2024
47.69 M Stocks
Jan 1, 2025
47.03 M Stocks
Jan 1, 2026 (e)
47.03 M Stocks
Jan 1, 2027 (e)
47.03 M Stocks
Jan 1, 2028 (e)
47.03 M Stocks

Core Laboratories stock splits

In Core Laboratories's history, there have been no stock splits.

Core Laboratories Dividend History

19 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.01USDYTD—1×
Feb 13, 20260.01USD 0.0%1/1
20250.04USD 0.0%4×
Feb 10, 20250.01USD 0.0%1/4
May 5, 20250.01USD 0.0%2/4
Aug 4, 20250.01USD 0.0%3/4
Nov 3, 20250.01USD 0.0%4/4
20240.04USD 0.0%4×
20230.04USD 0.0%4×
20220.04USD 0.0%4×
20210.04USD↓ 85.7%4×
20200.28USD↓ 87.3%4×
20192.20USD 0.0%4×
20182.20USD 0.0%4×
20172.20USD 0.0%4×

Core Laboratories dividend history and estimates

In 2025, Core Laboratories paid a dividend amounting to 0.04 USD. Dividend means that Core Laboratories distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
0.04 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.04 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.04 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.04 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.04 USD
0.00 USD
0.00 USD
Jan 1, 2026 (e)
0.01 USD
0.03 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
0.04 USD
0.00 USD
Jan 1, 2028 (e)
0.00 USD
0.04 USD
0.00 USD

Core Laboratories dividend payout ratio

In 2025, Core Laboratories had a payout ratio of 5.91%. The payout ratio indicates the percentage of the company's profits that Core Laboratories distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
9.52 %
Jan 1, 2022
9.52 %
Jan 1, 2023
5.18 %
Jan 1, 2024
6.07 %
Jan 1, 2025
5.91 %
Jan 1, 2026 (e)
4.88 %
Jan 1, 2027 (e)
5.01 %
Jan 1, 2028 (e)
2.93 %

Current Core Laboratories forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy10.00 % (1)
Hold30.00 % (3)
Sell60.00 % (6)
12M Price Target
14.28
Last Price
11.41
Currency
USD
12M Return Potential
25.15 %
LTM Return
0 %

Core Laboratories Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
4/29/20260.10USD129.57 MUSD2026 Q1
2/4/20260.19USD132.41 MUSD2025 Q4
1/29/20260.19USD132.41 MUSD2025 Q4
4/24/20240.26USD140.39 MUSD2024 Q1
1/30/20240.26USD141.18 MUSD2023 Q4
7/25/20230.23USD136.26 MUSD2023 Q2
4/25/20230.19USD129.06 MUSD2023 Q1
1/31/20230.20USD132.71 MUSD2022 Q4
10/26/20220.15USD127.71 MUSD2022 Q3
7/27/20220.14USD123.17 MUSD2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Core Laboratories stock

74/100
61
Environment
99
Social
62
Governance
E

Environment

20
Scope 1 - Direct Emissions9,714
Scope 2 - Indirect emissions from purchased energy10,285
Scope 3 - Indirect emissions within the value chain26,703
Total CO₂ emissions19,999
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees24.221
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Core Laboratories shareholder structure

% Name
20.63265%
Ariel Investments, LLC
Ariel Investments, LLC
11.16801%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
11.01702%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
8.19507%
Fred Alger Management, LLC
Fred Alger Management, LLC
7.59782%
EARNEST Partners, LLC
EARNEST Partners, LLC
4.18726%
Boston Trust Walden Company
Boston Trust Walden Company
...

Core Laboratories Executives and Management Board

LB

Mr. Lawrence Bruno

(62)

Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer · since 2015

Compensation6.55 M USD
CH

Mr. Christopher Hill

(52)

Chief Financial Officer, Senior Vice President

Compensation2.48 M USD
GG

Ms. Gwendolyn Gresham

(54)

Senior Vice President, Corporate Development and Investor Relations

Compensation1.30 M USD
MT

Mr. Mark Tattoli

(50)

Senior Vice President, General Counsel, Secretary

Compensation749,881.00 USD
MC

Ms. Martha Carnes

(61)

Presiding Non-Executive Lead Independent Member of the Supervisory Board

Compensation248,344.00 USD

Core Laboratories Supply Chain

Core Laboratories Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#Name1M3M6M1Y2YTrend
1
Archer
0.63
-0.04
-0.48
0.42
0.73

Frequently asked questions about Core Laboratories

Analysts currently set an average price target of 16.15 USD for the Core Laboratories stock (median: 14.28 USD), implying +41.5 % versus the latest price. The consensus is based on 10 analyst ratings.

Core Laboratories Analyst Price Targets 2026

All fundamentals and in-depth analysis of Core Laboratories

Our stock analysis for Core Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Core Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Core Laboratories Stock
Core Laboratories Revenue→
Core Laboratories Stock
Core Laboratories Net Income→
Core Laboratories Stock
Core Laboratories P/E→
Core Laboratories Stock
Core Laboratories P/S→
Core Laboratories Stock
Core Laboratories EBIT→
Core Laboratories Stock
Core Laboratories Dividend→
Core Laboratories Stock
Core Laboratories Directors Dealings→
Core Laboratories Stock
Core Laboratories Stocks→
Core Laboratories Stock
Core Laboratories Market capitalization→
Core Laboratories Stock
Core Laboratories Debt→
Core Laboratories Stock
Core Laboratories Liabilities→
Core Laboratories Stock
Core Laboratories Equity→
Core Laboratories Stock
Core Laboratories AAQS→
Core Laboratories Stock
Core Laboratories Employees→
Core Laboratories Stock
Core Laboratories ROE→
Core Laboratories Stock
Core Laboratories ROA→
Core Laboratories Stock
Core Laboratories ROCE→
Core Laboratories Stock
Core Laboratories News→
Core Laboratories Stock
Core Laboratories Analyst Price Targets→

Energy Stocks

CosanCoolan GroupCosan SA ADRConoilCOSCO Shipping Energy Transportation CoConocoPhillipsCosmo Energy Holdings CoCondor PetroleumCrescent EnergyCondor EnergyCriterium EnergyCondor EnergiesAll Stocks A–Z →